CompletedNCT04737720

Intravenous ACP-501 for Familial LCAT Deficiency (rhLCAT)

Studying Familial LCAT deficiency

Last synced from ClinicalTrials.gov May 4, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Principal Investigator: Robert D Shamburek, M.D.
National Heart, Lung, and Blood Institute (NHLBI)
Intervention: Recombinant LCAT(drug)
Enrollment: 1 enrolled
Eligibility: 18-100 years · All sexes
Timeline: 2013

Study locations (1)

National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04737720 on ClinicalTrials.gov

← Back to all trials